General Information of Drug (ID: DMZ8AOC)

Drug Name
JNJ-81201887
Synonyms JNJ-1887?
Indication
Disease Entry ICD 11 Status REF
Macular degeneration 9B78.3 Phase 2 [1]
Cross-matching ID
TTD ID
DJ1L4K

References

1 ClinicalTrials.gov (NCT05811351) A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD). U.S.National Institutes of Health.